BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 91806)

  • 21. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J
    Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment maintaining complete remission in Hodgkin's disease].
    Armata J
    Pol Tyg Lek; 1981 Feb; 36(8):301-4. PubMed ID: 7022410
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP; Young RC; Berard CW; DeVita VT
    Arch Intern Med; 1973 Mar; 131(3):388-90. PubMed ID: 4569375
    [No Abstract]   [Full Text] [Related]  

  • 24. Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Prosnitz LR; Farber LR; Fischer JJ; Bertino JR
    Radiology; 1973 Apr; 107(1):187-93. PubMed ID: 4689429
    [No Abstract]   [Full Text] [Related]  

  • 25. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination chemotherapy of acute leukemia and Hodgkin's disease.
    Frei E
    JAMA; 1972 Nov; 222(9):1168. PubMed ID: 4678057
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy in the treatment of Hodgkin's disease.
    Canellos GP; Come SE; Skarin AT
    Semin Hematol; 1983 Jan; 20(1):1-24. PubMed ID: 6189191
    [No Abstract]   [Full Text] [Related]  

  • 28. Towards curative treatment of advanced Hodgkin's disease.
    Falkson HC; Falkson G
    S Afr Med J; 1975 Sep; 49(38):1545-9. PubMed ID: 1179225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children.
    Armata J; Stopyrowa J; Depowski M; Strzeszynski J; Borkowski W; Kaczor Z; Depowska T
    Acta Paediatr Scand; 1978 May; 67(3):269-73. PubMed ID: 350007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
    Suon SZ
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
    [No Abstract]   [Full Text] [Related]  

  • 31. Letter: Chemotherapy of Hodgkin's disease.
    Winokur SH
    N Engl J Med; 1974 Dec; 291(24):1309. PubMed ID: 4431438
    [No Abstract]   [Full Text] [Related]  

  • 32. Subacute sensory neuropathy with remission: an association with lymphoma.
    Sagar HJ; Read DJ
    J Neurol Neurosurg Psychiatry; 1982 Jan; 45(1):83-5. PubMed ID: 6278098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug therapy of Hodgkin's disease].
    Gallmeier WM; Bruntsch U
    Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
    [No Abstract]   [Full Text] [Related]  

  • 34. BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease.
    Durant JR; Gams RA; Velez-Garcia E; Bartolucci A; Wirtschafter D; Dorfman R
    Cancer; 1978 Nov; 42(5):2101-10. PubMed ID: 719600
    [No Abstract]   [Full Text] [Related]  

  • 35. A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.
    Anderson H; Deakin DP; Wagstaff J; Jones JM; Todd ID; Wilkinson PM; James RD; Steward WP; Blackledge G; Scarffe JH
    Br J Cancer; 1984 Jun; 49(6):695-702. PubMed ID: 6375711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP.
    Hagemeister FB; Fuller LM; Velasquez WS; Sullivan JA; North L; Butler JJ; Johnston DA; Shullenberger CC
    Cancer Treat Rep; 1982 Apr; 66(4):789-98. PubMed ID: 7074649
    [No Abstract]   [Full Text] [Related]  

  • 37. [The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials].
    Zittoun R; Eghbali H; Audebert A; Rojouan J; David B; Blanc CM; Hoerni B; Debray J
    Bull Cancer; 1987; 74(2):151-7. PubMed ID: 2440504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cure of disseminated Hodgkin's disease: prospects and problems.
    Streuli RA; Ultmann JE
    Ann Intern Med; 1980 May; 92(5):693-5. PubMed ID: 7387012
    [No Abstract]   [Full Text] [Related]  

  • 39. Involved-field radiotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tirelli U; Bortolus R; van 't Veer MB; Lybeert ML; Keuning JJ; Carde P; Girinsky T; van der Maazen RW; Tomsic R; Vovk M; van Hoof A; Demeestere G; Lugtenburg PJ; Thomas J; Schroyens W; De Boeck K; Baars JW; Kluin-Nelemans JC; Carrie C; Aoudjhane M; Bron D; Eghbali H; Smit WG; Meerwaldt JH; Hagenbeek A; Pinna A; Henry-Amar M;
    N Engl J Med; 2003 Jun; 348(24):2396-406. PubMed ID: 12802025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term follow-up of combination chemotherapy-radiotherapy of stage III Hodgkin's disease: a Cancer and Acute Leukemia Group B study.
    Hoogstraten B; Glidewell O; Holland JF; Blom J; Stutzman L; Nissen NI; Perlberg HJ; Kramer S
    Cancer; 1979 Apr; 43(4):1234-44. PubMed ID: 445326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.